X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16310) 16310
Publication (1246) 1246
Book Review (416) 416
Book Chapter (238) 238
Dissertation (65) 65
Magazine Article (52) 52
Conference Proceeding (37) 37
Government Document (9) 9
Book / eBook (8) 8
Newspaper Article (6) 6
Data Set (2) 2
Presentation (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bisphosphonates (10070) 10070
humans (7857) 7857
index medicus (6060) 6060
female (5182) 5182
osteoporosis (5168) 5168
bisphosphonate (3994) 3994
male (3642) 3642
zoledronic acid (2883) 2883
middle aged (2812) 2812
aged (2784) 2784
diphosphonates - therapeutic use (2777) 2777
animals (2715) 2715
alendronate (2351) 2351
endocrinology & metabolism (2342) 2342
bone density conservation agents - therapeutic use (2173) 2173
oncology (1776) 1776
fractures (1751) 1751
bone (1695) 1695
orthopedics (1669) 1669
diphosphonates - adverse effects (1658) 1658
diphosphonates - administration & dosage (1552) 1552
bones (1533) 1533
diphosphonates - pharmacology (1481) 1481
medicine & public health (1472) 1472
bone density conservation agents - adverse effects (1462) 1462
osteonecrosis (1437) 1437
therapy (1409) 1409
postmenopausal women (1391) 1391
osteoporosis - drug therapy (1378) 1378
risk factors (1360) 1360
pamidronate (1320) 1320
cancer (1314) 1314
adult (1298) 1298
aged, 80 and over (1269) 1269
in-vitro (1266) 1266
phosphonates (1259) 1259
pharmacology & pharmacy (1245) 1245
dentistry, oral surgery & medicine (1239) 1239
bone density conservation agents - administration & dosage (1230) 1230
bone density - drug effects (1188) 1188
dentistry (1183) 1183
care and treatment (1182) 1182
analysis (1169) 1169
rats (1152) 1152
diphosphonates (1114) 1114
treatment outcome (1112) 1112
drug therapy (1093) 1093
rheumatology (1093) 1093
women (1082) 1082
surgery (1042) 1042
prevention (1041) 1041
postmenopausal osteoporosis (1023) 1023
bone neoplasms - secondary (1017) 1017
mice (1004) 1004
research (990) 990
bone density (966) 966
bone mineral density (957) 957
bone metastases (921) 921
bone-mineral density (915) 915
denosumab (907) 907
breast cancer (887) 887
health aspects (886) 886
risk (877) 877
breast-cancer (814) 814
double-blind (812) 812
necrosis (805) 805
bone density conservation agents - pharmacology (804) 804
osteoporosis, postmenopausal - drug therapy (803) 803
endocrinology (774) 774
bone neoplasms - drug therapy (765) 765
risedronate (763) 763
apoptosis (737) 737
metastasis (736) 736
medicine, general & internal (725) 725
density (723) 723
retrospective studies (721) 721
jaw (710) 710
risk-factors (701) 701
bone resorption (654) 654
fracture (649) 649
imidazoles - therapeutic use (647) 647
nitrogen-containing bisphosphonates (642) 642
time factors (629) 629
disease (616) 616
calcium (612) 612
article (597) 597
management (597) 597
multiple-myeloma (584) 584
vitamin d (566) 566
cells (559) 559
dose-response relationship, drug (557) 557
imidazoles - pharmacology (544) 544
osteoclasts (544) 544
patients (537) 537
resorption (537) 537
medicine, research & experimental (536) 536
internal medicine (533) 533
pain (533) 533
administration, oral (530) 530
medicine (527) 527
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15127) 15127
German (419) 419
French (323) 323
Spanish (243) 243
Japanese (138) 138
Korean (63) 63
Portuguese (59) 59
Czech (54) 54
Italian (47) 47
Polish (47) 47
Russian (45) 45
Chinese (41) 41
Hungarian (18) 18
Turkish (18) 18
Croatian (7) 7
Slovenian (6) 6
Slovak (4) 4
Dutch (3) 3
Norwegian (3) 3
Arabic (2) 2
Belarusian (1) 1
Bosnian (1) 1
Estonian (1) 1
Lithuanian (1) 1
Persian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Dental Journal, ISSN 0007-0610, 05/2019, Volume 226, Issue 10, pp. 794 - 794
Journal Article
JAMA: Journal of the American Medical Association, ISSN 0098-7484, 11/2013, Volume 310, Issue 20, pp. 2195 - 2195
Levin and Luder talk about intravenous bisphosphonates, which are primarily used for and are effective in the treatment and management of cancer-related... 
Bisphosphonates
Journal Article
European Journal of Cancer, ISSN 0959-8049, 01/2013, Volume 49, Issue 2, pp. 416 - 430
Aim To evaluate the evidence for denosumab for the treatment of bone metastases secondary to solid tumours and, using a network meta-analysis, indirectly... 
Bisphosphonates
Journal Article
Journal of the American Dental Association, ISSN 0002-8177, 11/2013, Volume 144, Issue 11, pp. 1294 - 1294
An abstract of a study by Hodges et al evaluating the association between radiographic evidence of periodontal disease and bisphosphonate-related osteonecrosis... 
Bisphosphonates
Journal Article
by Anon
British Dental Journal, ISSN 0007-0610, 04/2013, Volume 214, Issue 7, pp. 349 - 349
  Ozone offers 'a promising...therapeutic option'. 
Bisphosphonates
Journal Article
New Biotechnology, ISSN 1871-6784, 01/2013, Volume 30, Issue 2, pp. 114 - 123
As isoprenoid biosynthetic pathway has gained importance since last few years, key enzymes of this pathway have been characterized and their functional roles... 
Bisphosphonates
Journal Article
Journal of Oral Implantology, ISSN 0160-6972, 01/2013, Volume 39, Issue 4, pp. 510 - 510
Bisphosphonate (BP) drugs are a commonly prescribed group of medications used in the treatment of metabolic and oncologic bone disorders. The aim of this study... 
Bisphosphonates
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 05/2010, Volume 24, Issue 4, pp. 564 - 568
Fatigue associated with recovery from muscle damage has recently been linked to increases in brain and muscle proinflammatory cytokines. However, little is... 
Bisphosphonates
Journal Article
PLoS ONE, 12/2013, Volume 8, Issue 12
Background Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious... 
Bisphosphonates
Journal Article
PLoS ONE, 05/2013, Volume 8, Issue 5
Zoledronic acid (ZOL), a third-generation bisphosphonate that strongly inhibits osteoclast activity, is widely used for the treatment of bone metastasis from a... 
Bisphosphonates
Journal Article
PLoS ONE, 03/2013, Volume 8, Issue 3
We examined anti-tumor effects of zoledronic acid (ZOL), one of the bisphosphonates agents clinically used for preventing loss of bone mass, on human... 
Bisphosphonates
Journal Article
Expert Opinion on Drug Safety, ISSN 1474-0338, 07/2016, Volume 15, Issue 7, pp. 925 - 935
Journal Article
Pamidronate - a promising new candidate for the management of spondyloarthropathy, 12/2005
Bisphosphonate group of agents are known for their anti-bone resorptive properties. However, recently their anti-inflammatory and anti-arthritis properties... 
Pamidronate, Bisphosphonates, Ankylosing spondylitis, spondyloarthropathy
Journal
Orthopedic Journal of China, ISSN 1005-8478, 10/2011, Volume 19, Issue 20, pp. 1701 - 1705
[Objective] To assess the efficacy and safety of the incidence of fracture after risedronate for the treatment of primary postmenopausal osteoporosis. [Method]... 
Bisphosphonates
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 6/2018, Volume 26, Issue 6, pp. 1905 - 1915
Journal Article
11/2013
Background: Bisphosphonate related osteonecrosis of the jaws (BRONJ) is a severe but extremely rare complication of prolonged treatment with bisphosphonates.... 
0567 | Ontario Dentists | Bisphosphonates | Knowledge
Dissertation
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.